To conclude, our study uncovered the prognostic value and carcinogenic role of USP13 in prostate cancer and showed that overexpression of USP13 may lead to activation of cancer-driving signaling pathways, such as PI3k, Wnt and AR. This evidence concerns the gene AR and prostate carcinoma.